doc. MUDr. Igor Kiss, Ph.D., MBA
Department head, Comprehensive Cancer Care Department
correspondence Address:
Žlutý kopec 534/7, 656 53 Brno
e‑mail: | igor.kiss@med.muni.cz |
---|
social and academic networks: |
---|
Total number of publications: 261
2021
-
Predikce odpovědi na léčbu imunoterapiícheckpoint inhibitory u pacientů s pokročilýmisolidními nádory
Klinicka Onkologie, year: 2021, edition: 34 (Suppl 2)
-
Second primary malignancies in colorectal cancer patients
Nature Scientific Reports, year: 2021, volume: 11, edition: 1, DOI
-
The Impact of Diabetes Mellitus on the Second Primary Malignancies in Colorectal Cancer Patients
Frontiers in Oncology, year: 2021, volume: 10, edition: January 2021, DOI
-
The role of multidisciplinary team and molecular tumor board in the treatment of a patient with lung cancer.
Časopis Klinická onkologie, year: 2021, edition: 34(Supplementum 1), DOI
-
The use of cisplatin in patients after kidney transplantation with chronic renal insufficiency Is the benefit higher than potential risks in therapy of non-seminomatous germ cell tumors?
Medicine, year: 2021, volume: 100, edition: 24, DOI
-
Tooth agenesis: What do we know and is there a connection to cancer?
Clinical Genetics, year: 2021, volume: 99, edition: 4, DOI
2020
-
Cytoreductive Nephrectomy and Overall Survival of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy-Data from the National Renis Registry
Cancers, year: 2020, volume: 12, edition: 10, DOI
-
Everolimus-related unilateral abdominal lymphedema in a renal cancer patient A case report
Medicine, year: 2020, volume: 99, edition: 42, DOI
-
Factors associated with effectiveness of trifluridine/tipiracil versus regorafenib in patients with pretreated metastatic colorectal cancer (mCRC)
Year: 2020, type: Conference abstract
-
Hepatocellular carcinoma: Gene expression profiling and regulation of xenobiotic-metabolizing cytochromes P450
Biochemical Pharmacology, year: 2020, volume: 177, edition: JUL, DOI